Skip to main content
SpringerLink
Log in

Dermatika

  • Chapter
Book cover Arzneiverordnungs-Report 2010

  • 702 Accesses

Zusammenfassung

Dermatika zählen in Deutschland zu den verordnungsstärksten Arzneimitteln. Ihre Anwendungsgebiete sind sehr unterschiedlich. Entsprechend heterogen sind die Stoffklassen, die von den Corticosteroidexterna über die Antimykotika – sofern präferenziell zur Behandlung von Dermato- bzw. Onychomykosen zugelassen – sowie die Wundbehandlungsmittel bis zu den Hautschutz- und Pflegemitteln reichen (Abbildung 22.1). Antimykotika mit anderen Indikationen finden sich in Kapitel 9 (Antibiotika und Chemotherapeutika), Kapitel 26 (Gynä-kologika) sowie in Kapitel 34 (Mund- und Rachentherapeutika).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ågren MS, Ostenfeld U, Kallehave F, Gong Y, Raffn K, Crawford ME, Kiss K, Friis-Møller A, Gluud C, Jorgensen LN (2006): A randomized, double-blind, placebo-controlled multicenter trial evaluating topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Repair Regen 4: 526-535.

    Google Scholar 

  • Alston SJ, Cohen BA, Braun M (2003): Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics 111: 201–203.

    PubMed  Google Scholar 

  • Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P et al. (1994): Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 30: 977–981.

    CAS  PubMed  Google Scholar 

  • Ammon HPT, Sabieraj J, Kaul R (1996): Kamille. Mechanismus der antiphlogisti-schen Wirkung von Kamillenextrakten und -inhaltsstoffen. Dtsch Apoth Ztg 136: 1821–1834.

    Google Scholar 

  • Andrews MG, Burns M (2008): Common tinea infections in children. Am Fam Physician 77: 1415-1420.

    PubMed  Google Scholar 

  • Anonymus (2002): New treatments for actinic keratoses. Medical Letter 44: 57–58.

    Google Scholar 

  • Antille C, Saurat JH, Lübbe J (2004): Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. Arch Dermatol 140: 457-460.

    PubMed  Google Scholar 

  • Arican O, Sasmaz S, Ozbulu O (2006): Increased suicidal tendency in a case of psoriasis vulgaris under acitretin treatment. J Eur Acad Dermatol Venerol 20: 464-465.

    CAS  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (1999): Nutzen und Risiken durch Fumarsäure-Ester bei der Therapie der Psoriasis. Dtsch Ärztebl 96: A-721.

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2005a): Myopathie nach Tacrolimus-Salbe (Protopic®). Dtsch Ärztebl 102: A3138.

    Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2005b): Allergisches Kontaktekzem unter Bufexamac. Dtsch Ärztebl 102: A3285.

    Google Scholar 

  • Arzneimittelkommsission der deutsche Ärzteschaft (2006) Psychiatrische Reaktionen nach Terninafin (Lamisil®). Dtsch Ärztebl 103: A3432.

    Google Scholar 

  • Aschoff R, Wozel G, Meurer M (2003): Aktuelle Aspekte der topischen Psoriasisbehandlung. Hautarzt 54: 237–241.

    CAS  PubMed  Google Scholar 

  • Azoulay L, Blais L, Koren G, LeLorier J, Bérard A (2008): Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover-study. J Clin Psychiatry 69: 526-532.

    CAS  PubMed  Google Scholar 

  • Baran R, Kaoukhov A (2005): Topical antifungal drugs fort he treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venerol 19: 21–29.

    CAS  Google Scholar 

  • Baran R, Hay RJ, Garduno JI (2008a): Review of antifungal therapy and the severity index for assessing onychomycosis: part I. J Dermatolog Treat 19: 72-81.

    CAS  Google Scholar 

  • Baran R, Hay RJ, Garduno JI (2008b): Review of antifungal therapy, part II: treatment rationale, including specific patient populations. J Dermatolog Treat 19: 168-175.

    CAS  Google Scholar 

  • Bell-Syer SEM, Hart R, Crawford F, Torgerson DJ, Tyrell W, Russell I (2006): Oral treatments for fungal infections of the skin of the foot (Cochrane Review). In: The Cochrane Library, Issue 1 2006. Oxford: Update Software.

    Google Scholar 

  • Bergin SM, Wraight P (2006): Silver based dressings and topical agents for treating diabetic foot ulcers. Cochrane Darabase Syst Rev 2008 Jan 25:CD005082.

    Google Scholar 

  • Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA,; Multinational Study Group (2003): Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double-blind, parallel group study. Brit Med J 326: 1367–1373.

    CAS  PubMed  Google Scholar 

  • Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke W-H (2003): Efficacy of dexpanthenol in skin protection against irritation: a double-blind, placebo-controlled study. Contact Dermatitis 49: 80–84.

    CAS  PubMed  Google Scholar 

  • Boguniewicz M, Leung DY (2010): Recent insights into atopic dermatitis and implications for management of infectious complications. J Allergy Clin Immunol 125: 4-13.

    PubMed  Google Scholar 

  • Bradley M, Cullum N, Sheldon T (1999): The debridement of chronic wounds: a systematic review. Health Technol Assess 3: 1–78.

    CAS  PubMed  Google Scholar 

  • Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC, Landthaler M (2005): Dermato-logie und Venerologie, 5. Auflage. Springer Medizin Verlag, Heidelberg.

    Google Scholar 

  • Bristow IR, Baran R (2006): Topical and oral combination therapy for toenail onycho-mycosis. An updated review. J Am Podiatr Med Associat 96: 116–119.

    Google Scholar 

  • Buys LM (2007): Treatment options for atopic dermatitis. Am Fam Physician 75: 523–528.

    PubMed  Google Scholar 

  • Calow T, Oberle K, Bruckner-Tuderman L, Jakob T, Schumann H (2009): Contact dermatitis due to use of Octenisept(R) in wound care. J Dtsch Dermatol Ges 7: 759–765.

    PubMed  Google Scholar 

  • Casciano J, Amaya K, Doyle J, Arikian S, Shear N, Haspel M, Kahler K (2003): Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. Manag Care 12: 47–54.

    PubMed  Google Scholar 

  • Christiansen B (1988): Untersuchungen über die Wirksamkeit eines Hautdesinfektionsmittels mit kationenaktivem Zusatz. Zbl Bakt Hyg B 186:368-374.

    CAS  Google Scholar 

  • Conde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR (2007): Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol 6: 495-498.

    PubMed  Google Scholar 

  • Crawford F, Young P, Godfrey C, Bell-Syer SEM, Hart R, Brunt E, Russel I (2002): Oral treatments for toenail onychomycosis. Arch Dermatol 138: 811–816.

    CAS  PubMed  Google Scholar 

  • Crawford F, Hollis S (2007): Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2007 Jul 18 (3): CD001434.

    Google Scholar 

  • Darkes MJM, Scott LJ, Goa KL (2003): Terbinafine. A review of its use in onychomycosis in adults. Am J Clin Dermatol 4: 39–65.

    PubMed  Google Scholar 

  • Daschner F (1987): Sind Lokalantibiotika bei Hautinfektionen sinnvoll? Arzneiverordnung 4: 41–46.

    Google Scholar 

  • De Gannes GC, Ghoreishi M, Pope J, Russell A, Bell D, Adams S, Shojania K, Martinka M, Dutz JP (2007): Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions. Arch Dermatol 143: 223–231.

    PubMed  Google Scholar 

  • Deutsche Dermatologische Gesellschaft (1998): Akne und ihre Subtypen. Leitlinien der Deutschen Dermatologischen Gesellschaft. AWMF-Leitlinien-Register Nr. 013/017, http://leitlinien.net.

  • Deutsche Dermatologische Gesellschaft (2009a): Topische Dermatotherapie mit Glukokortikoiden – Therapeutischer Index. AWMF-Leitlinien-Register Nr. 013/034, http://leitlinien.net.

  • Deutsche Dermatologische Gesellschaft (2009b): Therapie der Psoriasis vulgaris. Leitlinien der Deutschen Dermatologischen Gesellschaft. AWMF-Leitlinien-Register Nr. 013/001, http://leitlinien.net.

  • Deutsche Dermatologische Gesellschaft und Berufsverband Deutscher Dermatologen (2009): Therapie des atopischen Ekzems mit Calcimeurin-Inhibitoren. AWMF-Leitlinien-Register Nr. 013/037, http://leitlinien.net.

  • Deutsche Dermatologische Gesellschaft und Deutschsprachige Mykologische Gesellschaft (2008): Tinea der freien Haut. AWMF-Leitlinien-Register Nr. 013-002. http://leitlinien.net/

  • Deutsche Dermatologische Gesellschaft, Deutschsprachige Mykologische Gesellschaft und Berufsverband der Deutschen Dermatologen (2005): Candidose der Haut. AWMF-Leitlinien-Register Nr. 013/005, http://leitlinien.net.

  • Deutsche Dermatologische Gesellschaft, Deutschsprachige Mykologische Gesellschaft und Berufsverband der Deutschen Dermatologen (2006): Onychomykose. AWMF-Leitlinien-Register Nr. 013/003, http://leitlinien.net.

  • Deutsche Dermatologische Gesellschaft, Österreichische Gesellschaft für Dermatologie und Venerologie, Arbeitskreis Pharmaökonomie in der Dermatologie et al. (2008): Neurodermitis, AWMF-Leitlinien-Register Nr. 013/027, http://leitlinien.net.

  • Dinnendahl V, Fricke U (Hrsg.) (2010): Arzneistoff-Profile, Basisinformation über arzneilich wirksame Wirkstoffe. Stammlieferung 1982 mit 1. bis 23. Erg.-Lieferung 2010, Govi-Verlag Pharmazeutischer Verlag GmbH, Eschborn.

    Google Scholar 

  • Dobie D, Gray J (2004): Fusidic acid resistance in Staphylococcus aureus. Arch Dis Child 89: 74-77.

    CAS  PubMed  Google Scholar 

  • Ebner F, Heller A, Rippke F, Tausch I (2002): Topical use of dexpanthenol in skin disorders. Am J Clin Dermatol 3: 427–433.

    PubMed  Google Scholar 

  • Eifler-Bollen R, Fluhr JW (2005): Antimikrobiell wirksame Magistralrezepturen. Stellenwert in der Praxis und kritische Anmerkungen. Hautarzt 56: 752–758.

    CAS  PubMed  Google Scholar 

  • Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y et al. (2003): International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 148 (Suppl 63): 3–10.

    PubMed  Google Scholar 

  • El Sayed F, Ammoury A, Dhaybi R, Bazex J (2006): Rosaceiform eruption to pimecro-limus. J Am Acad Dermatol 54: 548–550.

    PubMed  Google Scholar 

  • Erbagci Z (2004): Topical therapy for dermatophytoses. Should corticosteroids be included? Am J Clin Dermatol 5: 375–384.

    Google Scholar 

  • European Medicines Agency (EMA) (2006): European Medicines Agency recommends cautious use of Protopic/Protopy and Elidel. http://www.emea.europa.eu/ pdfs/general/direct/pr/9888206en.pdf

  • European Medicines Agency (EMA) (2009): Raptiva (efalizumab) – Withdrawal of the marketing authorisation in the European Union. http://www.emea.europa.eu/humandocs/PDFs/EPAR/raptiva/48710709en.pdf

  • Falagas ME, Angelousi AG, Peppas G (2006): Imiquimod for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials. J Am Acad Dermatol 55: 537–538.

    PubMed  Google Scholar 

  • Fiorentino DF (2007): The yin and yang of TNF-α inhibition. Arch Dermatol 143: 233–236.

    CAS  PubMed  Google Scholar 

  • Fleischer AB jr, Abramovits W, Breneman D, Jaracz E; US/Canada tacrolimus ointment study group (2007): Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatol Treat 18: 151-157.

    CAS  Google Scholar 

  • Fleischer AB, Feldman SR (1999): Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Clin Ther 10: 1725–1731.

    Google Scholar 

  • Fölster-Holst R, Latussek E (2007): Synthetic tannins in dermatology--a therapeutic option in a variety of pediatric dermatoses. Pediatr Dermatol 24: 296-301.

    PubMed  Google Scholar 

  • Friese K, Neumann G, Siebert J (2003): Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis. Arch Gynecol Obstet 268: 194-197.

    CAS  PubMed  Google Scholar 

  • Fuchslochner M, Rzany B (2002): Orale anticholinerge Therapie der fokalen Hyperhidrose mit Methantheliniumbromid (Vagantin®). Hautarzt 53: 151-152.

    Google Scholar 

  • Gemeinsamer Bundesausschuss (2010): Richtlinie des Gemeinsamen Bundesausschusses über die Verordnung von Arzneimitteln in der vertragsärztlichen Versorgung (Arzneimittel-Richtlinie/AM-RL) in der Fassung vom 18. Dezember 2008/22. Januar 2009, veröffentlicht im Bundesanzeiger 2009, Nr. 49a, zuletzt geändert am 17. Dezember 2009, veröffentlicht im Bundesanzeiger 2010 Nr. 39: S. 996, in Kraft getreten am 12. März 2010.http://www.g-ba.de/downloads/62-492-420/AM-RL-2009-12-17_3.pdf.

  • George A, Rubin G (2003): A systematic review and mety-analysis of treatments for impetigo. Br J Gen Pract 53: 480–487.

    PubMed  Google Scholar 

  • Geria AN, Schwartz RA (2010): Impetigo update: new challenges in the era of methicillin resistance. Cutis 85: 65-70.

    PubMed  Google Scholar 

  • Gibbs S, Harvey I (2006): Topical treatments for cutaneous warts. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001781. DOI: 10.1002/14651858. CD001781.pub2.

    Google Scholar 

  • Gloor M (1982): Pharmakologie dermatologischer Externa. Springer-Verlag, Berlin Heidelberg New York.

    Google Scholar 

  • Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, Ziegler J (2002): Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 205: 46–53.

    CAS  PubMed  Google Scholar 

  • Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D (2003): Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49 (1 Suppl): S1–S37.

    PubMed  Google Scholar 

  • González U, Seaton T, Bergus G, Jacobson J, Martínez-Monzón C.(2007): Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004685.

    Google Scholar 

  • Gorman CR, White SW (2005): Rosaceiform dermatitis as a complication of treatment of facial seborrhoic dermattis with 1% pimecrolimus cream. Arch Dermatol 141: 1168.

    PubMed  Google Scholar 

  • Goulden V (2003): Guidelines for the management of acne vulgaris in adolescents. Paediatr. Drugs 5: 301–313.

    Google Scholar 

  • Griffiths CE, Barker JN (2007): Pathogenesis and clinical features of psoriasis. Lancet 370: 263-271.

    CAS  PubMed  Google Scholar 

  • Griffiths CE, Finlay AY, Fleming CJ, Barker JN, Mizzi F, Arsonnaud S (2006): A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. J Dermatolog Treat 17: 90-95.

    CAS  PubMed  Google Scholar 

  • Guenther LC (2004): Fixed-dose combination therapy for psoriasis. Am J Clin Dermatol 5: 71–77.

    PubMed  Google Scholar 

  • Gupta AK (2002): Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. J Am Pediatr Med Assoc 92: 272–286.

    Google Scholar 

  • Gupta AK, Cherman AM, Tyring SK (2005): Viral and nonviral uses of imiquimod: A review. J Cut Med Surg 8: 338–352.

    Google Scholar 

  • Gupta AK, Cooper EA (2008): Update in antifungal therapy of dermatophytosis. Mykopathologia 166: 353-367.

    Google Scholar 

  • Gupta AK, Cooper EA, Ryder JE, Nicol KA, Chow M, Chaudhry MM (2004): Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 5: 225–237.

    PubMed  Google Scholar 

  • Gupta AK, Skinner AR (2003): Ciclopirox fort he treatment of superficial fungal infections: a review. Int J Dermatol 42 (Suppl 1): 3–9.

    CAS  PubMed  Google Scholar 

  • Guttman-Yassky E, Hayek T, Muchnik L, Bergman R (2003): Acute rhabdomyolysis and myoglobinuria associated with isotretinoin treatment. Int J Dermatol 42: 499-500

    CAS  PubMed  Google Scholar 

  • Hadley G, Derry S, Moore RA (2006): Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol 126: 1251–1255.

    CAS  PubMed  Google Scholar 

  • Hahn C, Röseler S, Fritzsche R, Schneider R, Merk HF (1993): Allergic contact reaction to dexpanthenol: lymphocyte transformation test and evidence for microso-mal-dependent metabolism of the allergen. Contact Dermatitis 28: 81–83.

    CAS  PubMed  Google Scholar 

  • Haider A, Shaw JC (2004): Treatment of acne vulgaris. JAMA 292: 726–735.

    CAS  PubMed  Google Scholar 

  • Haugh M, Helou S, Boissel J P, Cribier BJ (2002): Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials. Br J Dermatol 147: 118–121.

    CAS  PubMed  Google Scholar 

  • Hauschild A, Kähler KC, Egberts F (2006): Moderne Behandlungsoptionen bei aktini-schen Keratosen der Haut. Dtsch Med Wochenschr 131: 447–452.

    CAS  PubMed  Google Scholar 

  • Harper JC (2008): Tailoring individualized treatment plans fpr acne. Cutis 81 (1 Suppl): 23-25.

    PubMed  Google Scholar 

  • Hengge UR, Ruzicka T, Schartz RA, Cork MJ (2006): Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 54: 1–15.

    PubMed  Google Scholar 

  • Hoare C, Li Wan Po A, Williams H (2000): Systematic review of treatments for atopic eczema. Health Technol Assess 4: 1–191.

    CAS  PubMed  Google Scholar 

  • Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN (2003): Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 149: 363–369.

    CAS  PubMed  Google Scholar 

  • Hoffmann R, Happle R (2000): Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment. Eur J Dermatol 10: 410–417.

    CAS  PubMed  Google Scholar 

  • Hornstein O P, Nürnberg E (Hrsg) (1985): Externe Therapie von Hautkrankheiten. Pharmazeutische und medizinische Praxis. Georg Thieme Verlag, Stuttgart New York.

    Google Scholar 

  • Hund M, Sinkgraven R, Rzany B (2004) Randomisierte, plazebokontrollierte klinische Doppelblindstudie zur Wirksamkeit und Verträglichkeit der oralen Therapie mit Methantheliniumbromid (Vagantin®) bei fokaler Hyperhidrose. J Dtsch Dermatol Ges 2: 343-349.

    PubMed  Google Scholar 

  • Jarvis B, Figgitt DP (2003): Topical 3% diclofenac in 2.5% hyaluronic acid gel. A review of its use in patients with actinic keratoses. Am J Clin Dermatol 4: 203–213.

    PubMed  Google Scholar 

  • Johnson MR, Hageboutros A, Wang K, High L, Smith JB, Diasio RB (1999): Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. Clin Cancer Res 5: 2006–2011.

    CAS  PubMed  Google Scholar 

  • Kaymak Y (2008): Creatine phosphokinase values during isotretinoin treatment for acne. Int J Dermatol 47: 398-401.

    CAS  PubMed  Google Scholar 

  • Knapp U (1995): Grundlagen der Wundheilung und Wundbehandlung. Med Monatsschr Pharm 18: 219–230.

    CAS  PubMed  Google Scholar 

  • Koning S, Verhagen A P, Suijlekom-Smit LWA, Morris A, Butler CC, Wouden JC (2006): Interventions for impetigo (Cochrane Review). In: The Cochrane Library, 2006 Issue 2. The Cochrane Collaboration, John Wiley & Sons, Ltd.

    Google Scholar 

  • Koo JYM (2005): New developments in topical sequential therapy for psoriasis. Skin Therapy Lett 10: 1–4.

    CAS  PubMed  Google Scholar 

  • Korting HC (1995): Dermatotherapie: ein Leitfaden. Springer-Verlag, Berlin Heidelberg New York.

    Google Scholar 

  • Korting HC, Schäfer-Korting M., Klövekorn W., Klövekorn G., Martin C., Laux P. (1995): Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 48: 461–465.

    CAS  PubMed  Google Scholar 

  • Korting HC, Schöllmann C (2009): Management der Acne vulgaris: Fokus auf Clin-damycin und Zink. Hautarzt 60: 42-47.

    CAS  PubMed  Google Scholar 

  • Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E (2007): A randomised study of topical 6% imiquimod vs. Topical 5-fluorouracil vs. Cryosur-gery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 157 (Suppl 2): 34-40.

    CAS  PubMed  Google Scholar 

  • Kujath P, Michelsen A (2008): Wunden – von der Physiologie zum Verband. Dtsch Ärztebl 105: 239-248.

    Google Scholar 

  • Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A, Nevo Y (2001): Clinical significance of markedly elevated serum creatine kinase levels in patients with acne on isotretinoin. Acta Derm Venereol 81: 350-352.

    CAS  PubMed  Google Scholar 

  • Langer A, Rogowski W (2009): Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Research 2009, 9:115 (doi:10.1186/1472-6963 -9-115)

    Google Scholar 

  • Lansdown AB (2004): A review of the use of silver in wound care: facts and fallacies. Br J Nurs 13 (6 Suppl): S6–S19.

    PubMed  Google Scholar 

  • Lansdown AB, Mirastschijski U, Stubbs N, Scanlon E, Ågren MS (2007): Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound Repair Regen 15: 2-16.

    PubMed  Google Scholar 

  • Lebwohl M (1999): The role of salicylic acid in the treatment of psoriasis. Int J Der-matol 38: 16–24.

    CAS  Google Scholar 

  • Lecha M, Effendy I, Feuilhade de Chauvin M, Di Chiacchio N, Baran R (2005): Treatment options – development of consensus guidelines. J Eur Acad Dermatol Venereol 19 (Suppl 1): 25–33.

    PubMed  Google Scholar 

  • Lee S, Selva D, Huilgol SC, Goldberg RA, Leibovitch I (2007): Pharmacological treatments for basal cell carcinoma. Drugs 67: 915–934.

    CAS  PubMed  Google Scholar 

  • Leung DYM (2001): Atopic dermatitis and the immune system: The role of superantigens and bacteria. J Am Acad Dermatol 45: S13–S16.

    CAS  PubMed  Google Scholar 

  • Lohde H, Stahlmann R (Hrsg.) (2004): Nadifloxacin – irrationaler Einsatz eines Flu-orchinolons zur lokalen Aknetherapie. Zeitschr Chemother 25: 27–29.

    Google Scholar 

  • Løkkevik E, Skovlund E, Reitan JB, Hannisdal E, Tanum G (1996): Skin treatment with Bepanthen cream versus no cream during radiotherapy. Acta Oncol 35: 1021–1026.

    PubMed  Google Scholar 

  • Lunan HN (1975): Topical treatment of the burn patient. Am J Hosp Pharm 32: 599–605.

    CAS  PubMed  Google Scholar 

  • Maiche AG, Gröhn P, Mäki-Hokkonen H (1991): Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30: 395–396.

    CAS  PubMed  Google Scholar 

  • Marqueling AL, Zane LT (2007): Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 26: 210-220.

    CAS  PubMed  Google Scholar 

  • Mason J, Mason AR, Cork MJ (2002): Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 146: 351–364.

    CAS  PubMed  Google Scholar 

  • Mayser P, Hensel J, Thoma W, Podobinska M, Geiger M, Ulbricht H Haak T (2004): Prevalence of fungal foot infections in patients with diabetes mellitus type 1 – underestimation of moccasin-type tinea. Exp Clin Endocrinol Diabetes 112: 264–268.

    CAS  PubMed  Google Scholar 

  • McClellan KJ, Noble S (2000): Topical metronidazole. A review of its use in rosacea. Am J Clin Dermatol 1: 191–199.

    CAS  PubMed  Google Scholar 

  • McIntyre WJ, Downs MR, Bedwell SA (2007): Treatment options for actinic keratoses. Am Fam Physician 76: 667-671.

    PubMed  Google Scholar 

  • Menezes de Padua CA, Schnuch A, Nink K, Pfahlberg A, Uter W (2008): Allergic contact dermatitis to topical drugs – epidemiological risk assessment. Pharmaco-epidemiol Drug Saf 2008 Mar 26, Epub ahead of print.

    Google Scholar 

  • Merk HF (2007): Topical diclofenac in the treatment of actinic keratoses. Int J Dermatol 46: 12–18.

    CAS  PubMed  Google Scholar 

  • Möhrenschlager M, Seidl HP, Ring J, Abeck D (2005): Pediatric tinea capitis. Recognition and management. Am J Clin Dermatol 6: 203–213.

    PubMed  Google Scholar 

  • Mrowietz U, Rostami-Yazdi M, Neureither M, Reich K (2009): 15 Jahre Fumaderm: Fumarsäureester für die systemische Behandlung der mittelschweren und schweren Psoriasis vulgaris. JDDG 7 (Suppl 2): S3-S16.

    PubMed  Google Scholar 

  • Müller G, Kramer A (2008) Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Antimicrob Chemother 61: 1281–1287.

    Google Scholar 

  • Muller A, Talon D, Potier A, Belle E, Cappelier G, Bertrand X (2005): Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units. Critical Care 9: R246–R250.

    PubMed  Google Scholar 

  • Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M (2008): Mutschler Arzneimittelwirkungen, Lehrbuch der Pharmakologie und Toxikologie, 9. Auflage. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.

    Google Scholar 

  • Naldi L, Griffiths CEM (2005): Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks. Br J Dermatol 152: 597–615.

    CAS  PubMed  Google Scholar 

  • Niedner R (1998): Kortikoide in der Dermatologie. UNI-MED Verlag, Bremen.

    Google Scholar 

  • Niedner R, Ziegenmeyer J (Hrsg) (1992): Dermatika. Therapeutischer Einsatz, Pharmakologie und Pharmazie. Wissenschaftliche Verlagsgesellschaft, Stuttgart.

    Google Scholar 

  • Opstelten W, Neven AK, Eekhof J (2008): Treatment and prevention of herpes labialis. Can Fam Physician 54: 1683-1687.

    PubMed  Google Scholar 

  • Oranje A P, Chosidow O, Sacchidanand S, Todd G, Singh K, Scangarella N, Shawar R, Twynholm M; TOC100224 Study Team (2007): Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. Dermatology 215: 331-340.

    CAS  PubMed  Google Scholar 

  • Palfreyman S, Nelson EA, Michaels JA (2007): Dressings for venous leg ulcers: systematic review and mety-analysis. Br Med J 335: 244-248.

    Google Scholar 

  • Paller AS, Lebwohl M, Fleischer AB jr, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ; US/Canada Tacrolimus Ointment Study Group (2005): Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 52: 810-822.

    PubMed  Google Scholar 

  • Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ, for the Psoriasis Foundation (2007): National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 143: 239–242.

    PubMed  Google Scholar 

  • Patel B, Siskin S, Krazmien R, Lebwohl M (1998): Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 38: 1010–1011.

    CAS  PubMed  Google Scholar 

  • Peserico A, Städtler G, Sebastian M, Fernandez RS, Vick K, Bieber T (2008): Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 158:801,807.

    Google Scholar 

  • Petersen EE, Doerr H W, Gross G, Petzoldt D, Weissenbacher ER, Wutzler P (1999): Der Herpes genitalis. Dtsch Ärztebl 96: A-2358–A2364.

    Google Scholar 

  • Post B, Jänner M (1971): Zur Indikation der Gerbstofftherapie in der Dermatologie. Klinische Erfahrungen mit Tannosynt. Ther Ggw 110: 1477–1494.

    CAS  PubMed  Google Scholar 

  • Qureshi AA, Fischer MA (2006): Topical calcineurin inhibitors for atopic dermatitis – Balancing clinical benefit and possible risks. Arch Dermatol 142: 633–637.

    PubMed  Google Scholar 

  • Raborn G W, McGaw W T, Grace M, Eng P, Percy J, Samuels S (1989): Herpes labialis treatment with acyclovir 5% modified aqueous cream: A double-blind, randomized trial. Oral Surg. Oral Med Oral Pathol Oral Radiol Endod 67: 676–679.

    CAS  Google Scholar 

  • Rigopoulos D, Rallis E, Gregoriou S, Larios G, Belyayeva Y, Gkouvi K, Katsambas A (2009): Treatment of Pseudomonas nail infections with 0.1% octenidine dihydro-chloride solution. Dermatology 218: 67–68.

    CAS  PubMed  Google Scholar 

  • Ring J, Fröhlich HH (1985): Wirkstoffe in der dermatologischen Therapie, 2. Aufl, Springer-Verlag, Berlin Heidelberg.

    Google Scholar 

  • Roberts DT, Taylor WD, Boyle J (2003): Guidelines for treatment of onychomycosis. Br J Dermatol 148: 402–410.

    CAS  PubMed  Google Scholar 

  • Ruzicka T (2006): Methylprednisolone aceponate in eczema and other inflammatory skin disorders – a clinical update. Int J Clin Pract 60: 85–92.

    CAS  PubMed  Google Scholar 

  • Sapijaszko MJA (2005): Imiquimod 5% cream (Aldara®) in the treatment of basal cell carcinoma. Skin Ther Lett 10: 2–5.

    CAS  Google Scholar 

  • Schäfer-Korting M, Schmid MH, Korting HC (1996): Topical glucocorticoids with improved risk-benefit ratio. Drug Safety 14: 375–385.

    PubMed  Google Scholar 

  • Schlievert PM, Strandberg KL, Lin YC, Peterson ML, Leung DY (2010): Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol 125: 39-49.

    CAS  PubMed  Google Scholar 

  • Schmitt J, Meurer M (2006): Topische Kombinationstherapien bei Psoriasis. Stellenwert von Calcitriol und Vitamin-D-Analoga. Hautarzt 57: 679–684.

    CAS  PubMed  Google Scholar 

  • Schneider LA, Hinrichs R, Scharfetter-Kochanek K (2007): Indikationen zur UVB-Phototherapie. Dtsch Med Wochenschr 132: 888–891.

    CAS  PubMed  Google Scholar 

  • Schnuch A, Gefeller O, Uter W (2005): Eine heimtückische und häufige Nebenwirkung: Kontaktallergien durch das Ekzemtherapeutikum Bufexamac. Ergebnisse des IVDK. Dtsch Med Wochenschr 130: 2881–2886.

    CAS  PubMed  Google Scholar 

  • Schnuch A, Szliska C, Uter W (2009): Allergisches Gesichtsekzem. Auswertungen des IVDK und Literaturübersicht. Hautarzt 60: 13-21.

    CAS  PubMed  Google Scholar 

  • Schülke & Mayr GmbH (2008): Wichtige Information zur Arzneimittelsicherheit von Octenisept® (Octenidinhydrochlorid, Phenoxyethanol) – Oedematöse Schwellungen und Gewebeschädigungen nach Einbringen unter Druck in Stichwunden bei handchirurgischen Eingriffe. Rote Hand Brief 13. Februar 2008, http://www.akdae.de/20/40/20080213.pdf.

  • Schulze-Dirks A, Frosch PJ (1988): Kontaktallergie auf Dexpanthenol. Hautarzt 39: 375–377.

    CAS  PubMed  Google Scholar 

  • Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D, International Wound Bed Preparation Advisory Board, Canadian Chronic Wound Advisory Board (2003): Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 49: 23–51.

    PubMed  Google Scholar 

  • Sigurgeirsson B, Elewski BE, Rich PA, Opper C, Cai B, Nyirady J, Bakshi R (2006): Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: A randomaized, double-blind comparison. J Dermatol Treatm 17: 38–44.

    CAS  Google Scholar 

  • Singer AJ, Dagum AB (2008): Current management of acute cutaneous wounds. N Engl J Med 359: 1037-1046.

    CAS  PubMed  Google Scholar 

  • Smith RG (2008): Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage 54: 16-34.

    PubMed  Google Scholar 

  • Solares CA, Batra PS, Hall GS, Citardi MJ (2006): Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol 27: 161–165.

    CAS  PubMed  Google Scholar 

  • Spruance SI, Kriesel JD (2002): Treatment of herpes simplex labialis. Herpes 9: 64–69.

    PubMed  Google Scholar 

  • Stille W, Brodt HR, Groll AH, Just-Nübling G (2005): Antibiotika-Therapie. Klinik und Praxis der antiinfektiösen Behandlung, 11. Auflage. Schattauer, Stuttgart-New York.

    Google Scholar 

  • Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H (2010): Topical silver for preventing wound infection. Cochrane Database Syst Rev 2010 Mar 17;3:CD006478.

    Google Scholar 

  • Strömberg HE, Ågren MS (1984): Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol 111: 461–468.

    PubMed  Google Scholar 

  • Sunderkötter C, Herrmann M, Jappe U (2006): Antimikrobielle Therapie in der Dermatologie. J Dtsch Dermatol Ges 4: 10–26.

    PubMed  Google Scholar 

  • Sweetman SC (ed) (2009): Martindale 36: The Complete Drug Reference, 36th ed, Pharmaceutical Press, London.

    Google Scholar 

  • Tadicherla S, Ross K, Shenefelt PD, Fenske NA (2009): Topical corticosteroids in dermatology. J Drugs Dermatol 8: 1093-1105.

    PubMed  Google Scholar 

  • Tan H-H (2004): Topical antibacterial treatments for acne vulgaris. Comparative review and guide to selection. Am J Clin Dermatol 5: 79–84.

    CAS  PubMed  Google Scholar 

  • Thaçi D, Schöfer H (2005): Topische Antibiotika zur Therapie von Hautinfektionen. Hautarzt 56: 381–396.

    PubMed  Google Scholar 

  • Thiboutot DM (2008 a): Overview of acne and its treatment. Cutis 81 (1 Suppl): 3-7.

    Google Scholar 

  • Thiboutot DM (2008 b): Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. J Drugs Dermatol 7: 13-16.

    Google Scholar 

  • Thielitz A, Gollnick H (2008): Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol 9: 369-381.

    PubMed  Google Scholar 

  • Thielitz A, Kratheim A, Gollnick H (2006): Update in retinoid therapy of acne. Dermatol Ther 19: 272–279.

    PubMed  Google Scholar 

  • Tredget EE, Shankowsky HA, Groeneveld A, Burrell R (1998): A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 19: 531–537.

    CAS  PubMed  Google Scholar 

  • Ubriani R, Van Voorhees AS (2007): Onset of psoriasis during treatment with TNF-α antagonists: a report of 3 cases. Arch dermatol 143: 270–272.

    PubMed  Google Scholar 

  • U.S. Food and Drug Adminstration (2005): Elidel (pimecrolimus) Cream and Pro-topic (tacrolimus) Ointment. http://www.fda.gov/cder/drug/advisory/elidel_pro-topic.htm.

  • Uter W, Geier J, Fuchs T (2000): Contact allergy to polidocanol, 1992 to 1999. J All Clin Immunol 106: 1203–1204.

    CAS  Google Scholar 

  • van de Kerkhof (2006): Consistent control of psoriasis by continuous long-term therapy: the promise of biological treatments. J Eur Acad Dermatol Venereol 20: 639–650.

    PubMed  Google Scholar 

  • van Zuuren EJ, Gupta AK, Gover MD, Graber M, Hollis S (2007): Systematic review of rosacea treatments. J Am Acad Dermatol 56: 107-1015.

    PubMed  Google Scholar 

  • von Krogh G (1978): Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study. Acta Derm Venereol 58: 163-168.

    Google Scholar 

  • von Krogh G, Longstaff E (2001): Podophyllin office therapy against condyloma should be abandoned. Sex Transm Inf 77: 409-412.

    Google Scholar 

  • Walluf-Blume D (1991): Aufbereitung und Nachzulassung von OTC-Arzneimitteln in den USA 1990. Pharm Ind 53: 152–158.

    Google Scholar 

  • Wananukul S, Limpongsanuruk W, Singalavanija S, Wisuthsarewong W (2006): Comparison of dexpanthenol and zinc oxide ointment with ointment base in the treatment of irritant diaper dermatitis from diarrhea: a multicenter study. J Med Assoc Thai 89: 1654-1658.

    PubMed  Google Scholar 

  • Warnecke J, Wendt A (1998): Anti-inflammatory action of pale sulfonated shale oile (ICHTHYOL pale) in UVB erythema test. Inflamm Res 47: 75–78.

    CAS  PubMed  Google Scholar 

  • Warshaw EM, Fett DD, Bloomfield HE, Grill J P, Nelson DB, Quintero V, Carver SM, Zielke GR, Lederle FA (2005): Pulse versus continuous terbinafine for onycho-mycosis: a randomized, double-blind, controlled study. J Am Acad Dermatol 53: 578–584.

    PubMed  Google Scholar 

  • Wickline MM (2004): Prevention and treatment of acute radiation dermatitis: a literature review. Oncol Nurs Forum 31: 237-247.

    PubMed  Google Scholar 

  • Wilkinson JD (1998): Fusidic acid in dermatology. Br J Dermatol 139 (Suppl 53): 37–40.

    CAS  PubMed  Google Scholar 

  • Williams H (2002): New treatments for topic dermatitis. Brit Med J 324: 1533–1534.

    PubMed  Google Scholar 

  • Wohlrab J (2006): Basistherapie der Psoriasis vulgaris. Hautarzt 57: 661–665.

    CAS  PubMed  Google Scholar 

  • Wolff HH, Kieser M (2007): Hamamelis in children with skin disorders and skin injuries: results of an observational study. Eur J Pediatr 166: 943-948.

    PubMed  Google Scholar 

  • Worret WI, Fluhr JW (2006): Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges 4: 293–300.

    PubMed  Google Scholar 

  • Wright JB, Lam K, Burrell RE (1998): Wound management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. Am J Infect Control 26: 572–577.

    CAS  PubMed  Google Scholar 

  • Yan J, Chen SL, Wang HN, Wu TX (2006): Meta-analysis of 5% imiquimod amd 0,5% podophyllotoxin in the treatment of condylomata acuminata. Dermatology 213: 218-223.

    CAS  PubMed  Google Scholar 

  • Yan J, Chen SL, Wang HN, Zhou W, Wang FS (2008): Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients. Pediatr Dermatol 25: 117-120.

    PubMed  Google Scholar 

  • Zaenglein AL, Thiboutot DM (2006): Expert Committee recommendations for acne managemant. Pediatrics 118: 1188–1199.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie, Universität zu Köln, Gleueler Straße 24, 50924, Köln

    Prof. Dr. rer. nat. Uwe Fricke

Authors
  1. Prof. Dr. rer. nat. Uwe Fricke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg

    Ulrich Schwabe

  2. AOK Schleswig-Holstein, Die Gesundheitskasse, Edisonstraße 70, 24145, Kiel

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fricke, U. (2010). Dermatika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2010. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-13380-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-13380-0_22

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-13379-4

  • Online ISBN: 978-3-642-13380-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation